News
The coronary stents market has become a vital segment within the broader cardiovascular healthcare industry. With the rising prevalence of coronary artery diseases and growing awareness of ...
In 2023, the adoption of coronary stent in India stands at a valuation of USD 843.8 million. This surge is attributed to the demand for minimally invasive procedures to address the rising cases of ...
Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...
In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved ...
Understanding calcified coronary artery disease, its risk factors, symptoms, diagnosis, treatment, and prevention for a ...
A major international study has found that heart patients, particularly seniors, may benefit more from newer blood-thinning ...
University of Iowa Health Care has become the first in Iowa to offer drug-coated balloon therapy for patients with blockages ...
[2,11,25,42] However, the main limitation of durable polymers are that they remain exposed for long periods of time to the coronary artery ... biodegradable polymer stents have been developed ...
Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures - ...
Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...
15d
MedPage Today on MSNPrasugrel Strategy Rolls Short DAPT and De-Escalation Into One4D-ACS trial investigators found that after placement of a drug-coated stent (DCS), the incidence of net adverse clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results